EFFICACY, SAFETY AND IMMUNOGENICITY OF SUBCUTANEOUS INFLIXIMAB (CT-P13 SC) MONOTHERAPY VERSUS COMBINATION THERAPY WITH IMMUNOSUPPRESSANTS – POST HOC ANALYSIS OF LIBERTY-CD STUDY AND LIBERTY-UC STUDY

Stefan Schreiber  1     Jean Frédéric Colombel  2     Steve Hanauer  3     William Sandborn  4     Bruce E. Sands     Silvio Danese  5     Sang Joon Lee  6     Sung Hyun Kim     Yunju Bae     Sunhee Lee     Seul Gi Lee     JoonHo Lee     Jong Min Kim     Siyoung Yang     Jimin Lee     Gahee Park     Juhyun Lee    
1 University Hospital Schleswig-Holstein, Kiel, Germany
2 Icahn School of Medicine at Mount Sinai, New York, United States
3 Northwestern University/ Feinberg School of Medicine, Chicago, IL, United States
4 University of California San Diego, La Jolla, United States
5 IRCCS San Raffaele Hospital, Milan, Italy
6 Celltrion, Inc, Incheon, Korea, Republic of

Topic
IBD

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing